4.7 Article

Natural product (-)-gossypol inhibits colon cancer cell growth by targeting RNA-binding protein Musashi-1

期刊

MOLECULAR ONCOLOGY
卷 9, 期 7, 页码 1406-1420

出版社

WILEY
DOI: 10.1016/j.molonc.2015.03.014

关键词

RNA binding protein; Wnt; Notch; Musashi-1; Colon cancer

类别

资金

  1. National Institutes of Health [R01 CA178831]
  2. K-INBRE Bridging Grant [P20 GM103418]
  3. Kansas Bioscience Authority Rising Star Award
  4. University of Kansas Cancer Center Pilot Grant
  5. NIH COBRE at KU CCET Pilot Project [P30 RR030926]
  6. NIH [R01 AI074856]
  7. University of Kansas Bold Aspiration Strategic Initiative Award

向作者/读者索取更多资源

Musashi-1 (MSI1) is an RNA-binding protein that acts as a translation activator or repressor of target mRNAs. The best-characterized MSI1 target is Numb mRNA, whose encoded protein negatively regulates Notch signaling. Additional MSI1 targets include the mRNAs for the tumor suppressor protein APC that regulates Wnt signaling and the cyclin-dependent kinase inhibitor P21(WAF-1). We hypothesized that increased expression of NUMB, P21 and APC, through inhibition of MSI1 RNA-binding activity might be an effective way to simultaneously downregulate Wnt and Notch signaling, thus blocking the growth of a broad range of cancer cells. We used a fluorescence polarization assay to screen for small molecules that disrupt the binding of MSI1 to its consensus RNA binding site. One of the top hits was (-)-gossypol (Ki = 476 +/- 273 nM), a natural product from cottonseed, known to have potent anti-tumor activity and which has recently completed Phase IIb clinical trials for prostate cancer. Surface plasmon resonance and nuclear magnetic resonance studies demonstrate a direct interaction of (-)-gossypol with the RNA binding pocket of MSI1. We further showed that (-)-gossypol reduces Notch/Wnt signaling in several colon cancer cell lines having high levels of MSI1, with reduced SURVIVIN expression and increased apoptosis/autophagy. Finally, we showed that orally administered (-)-gossypol inhibits colon cancer growth in a mouse xenograft model. Our study identifies (-)-gossypol as a potential small molecule inhibitor of MSI1-RNA interaction, and suggests that inhibition of MSI1's RNA binding activity may be an effective anti-cancer strategy. (C) 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Nanoscience & Nanotechnology

Cyclic RGD-Decorated Liposomal Gossypol AT-101 Targeting for Enhanced Antitumor Effect

Hao Liu, Ruirui Zhang, Dan Zhang, Chun Zhang, Zhuo Zhang, Xiujuan Fu, Yu Luo, Siwei Chen, Ailing Wu, Weiling Zeng, Kunyan Qu, Hao Zhang, Sijiao Wang, Houyin Shi

Summary: This study developed a RGD-decorated liposome for targeted delivery of (-)-Gosspol, which has inhibitory effects on various types of cancers. The liposome exhibited high drug loading efficiency, controlled particle size, sustained drug release, enhanced tumor targeting, and significant antitumor activity.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2022)

Article Multidisciplinary Sciences

Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors

Daichao Wu, Alexander Kolesnikov, Rui Yin, Johnathan D. Guest, Ragul Gowthaman, Anton Shmelev, Yana Serdyuk, Dmitry V. Dianov, Grigory A. Efimov, Brian G. Pierce, Roy A. Mariuzza

Summary: This study reveals the structural information of SARS-CoV-2-specific T-cell receptors (TCRs) bound to their peptide-MHC targets and explains the mechanisms behind their selection of specific germline genes and recognition of different variants. This has important implications for designing vaccines to elicit pan-coronavirus immunity.

NATURE COMMUNICATIONS (2022)

Article Biochemistry & Molecular Biology

Advances in Sulfonamide Kappa Opioid Receptor Antagonists:Structural Refinement and Evaluation of CNS Clearance

Huiyong Ma, Tarsis Brust, Kevin J. Frankowski, Kimberly M. Lovell, Michael D. Cameron, Laura M. Bohn, Jeffrey Aube

Summary: This study focused on the modification of a sulfonamide-based KOR antagonist series, resulting in a 4-fold increase in potency compared to the lead compound. The improved analogue exhibited suitable brain levels and a shorter clearance time.

ACS CHEMICAL NEUROSCIENCE (2022)

Article Biochemistry & Molecular Biology

Small-Molecule Disruptors of Mutant Huntingtin-Calmodulin Protein-Protein Interaction Attenuate Deleterious Effects of Mutant Huntingtin

Khushboo Kapadia, Ashley E. Trojniak, Kenneth B. Guzman Rodriguez, Nicholas J. Klus, Coral Huntley, Peter McDonald, Anuradha Roy, Kevin J. Frankowski, Jeffrey Aube, Nancy A. Muma

Summary: By disrupting the binding of mutant huntingtin protein to calmodulin, small-molecule compounds have shown protective effects against cytotoxicity and normalized receptor-stimulated calcium release in cell and mouse models of Huntington's disease.

ACS CHEMICAL NEUROSCIENCE (2022)

Review Chemistry, Multidisciplinary

HFIP in Organic Synthesis

Hashim F. Motiwala, Ahlam M. Armaly, Jackson G. Cacioppo, Thomas C. Coombs, Kimberly R. K. Koehn, Verrill M. Norwood IV, Jeffrey Aube

Summary: HFIP is a polar solvent that is widely used in organic synthesis for stabilizing ionic species, transferring protons, and engaging in various intermolecular interactions.

CHEMICAL REVIEWS (2022)

Review Pharmacology & Pharmacy

Strategic developments in the drug delivery of natural product dihydromyricetin: applications, prospects, and challenges

Ruirui Zhang, Hao Zhang, Houyin Shi, Dan Zhang, Zhuo Zhang, Hao Liu

Summary: Dihydromyricetin (DHM) is a natural flavonoid with various functions, and its development potential in pharmacy is great. However, it faces challenges such as low solubility, permeability, and stability. Although extensive research has been conducted, the transformation of DHM research results into market products is still insufficient.

DRUG DELIVERY (2022)

Editorial Material Gastroenterology & Hepatology

New Immune Role for Axin1 in Colon Cancer Suppression

Kristi L. Neufeld

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Pharmacology & Pharmacy

A double-layered gastric floating tablet for zero-order controlled release of dihydromyricetin: Design, development, and in vitro/in vivo evaluation

Ruirui Zhang, Houyin Shi, Sifang Li, Hao Zhang, Dan Zhang, Ailing Wu, Chun Zhang, Chunhong Li, Xiujuan Fu, Siwei Chen, Jiaoyue Shi, Yang Tian, Sihan Wang, Yu Wang, Hao Liu

Summary: This study developed a gastric floating tablet with a double-layered structure for controlled release of dihydromyricetin (DHM). The tablet showed high drug release rate, good floating ability, and prolonged retention time in the stomach. It also enhanced the bioavailability of DHM and exhibited potent and long-term therapeutic effects on systemic inflammation in rabbits.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2023)

Editorial Material Chemistry, Medicinal

Virtual Special Issue: New Drug Modalities in Medicinal Chemistry, Pharmacology, and Translational Science

Jeffrey Aube, Craig W. Lindsley, Christa E. Mueller

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Review Medicine, Research & Experimental

The role of mitochondria in the resistance of melanoma to PD-1 inhibitors

Fei Du, Lu-han Yang, Jiao Liu, Jian Wang, Lianpeng Fan, Suwit Duangmano, Hao Liu, Minghua Liu, Jun Wang, Xiaolin Zhong, Zhuo Zhang, Fang Wang

Summary: Malignant melanoma is a common tumor with high mortality rate. Immunotherapy combined with other treatment strategies is currently the mainstay of treatment for melanoma, but immune checkpoint inhibitors may not be effective in clinical treatment. This review comprehensively summarizes the role of mitochondria in melanoma, including its function in tumor cells and changes in mitochondrial function in melanoma resistant to PD-1 inhibitors, aiming to develop therapeutic strategies for improving the clinical response rate and patient survival.

JOURNAL OF TRANSLATIONAL MEDICINE (2023)

Review Plant Sciences

A systematical review on ethnobotanical, phytochemical and pharmacological aspects of Dendrobium nobile Lindl.

Qian Zhang, Xiujuan Fu, Hao Liu, Yangxi Chen, Siwei Chen, Hong Niu, Yu Luo, Hui Lei, Dan Zhang

Summary: This paper provides a systematic summary of the research on Dendrobium nobile Lindl (DNL) from 1935 to 2022, including its botanical characteristics, chemical composition, pharmacological activity, and toxicology. The stems of DNL contain alkaloids, polysaccharides, sesquiterpenes, Phenanthrenes, benzenes and other chemical components, with alkaloids and polysaccharides identified as the main active constituents. Extracts from DNL have shown various pharmacological activities, such as anti-tumor, blood sugar reduction, nerve protection, immune enhancement, anti-inflammation, and anti-aging.

PHYTOCHEMISTRY REVIEWS (2023)

Editorial Material Chemistry, Medicinal

Virtual Special Issue: New Drug Modalities in Medicinal Chemistry, Pharmacology, and Translational Science

Jeffrey Aube, Craig W. Lindsley, Christa E. Mueller

ACS MEDICINAL CHEMISTRY LETTERS (2023)

Editorial Material Chemistry, Medicinal

Virtual Special Issue: New Drug Modalities in Medicinal Chemistry, Pharmacology, and Translational Science

Jeffrey Aube, Craig W. Lindsley, Christa E. Mueller

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2023)

Article Immunology

Type I interferons drive MAIT cell functions against bacterial pneumonia

Juan Carlos Lopez-Rodriguez, Steven J. Hancock, Kelin Li, Stefania Crotta, Christopher Barrington, Alejandro Suarez-Bonnet, Simon L. Priestnall, Jeffrey Aube, Andreas Wack, Paul Klenerman, Jose A. Bengoechea, Patricia Barral

Summary: Mucosal-associated invariant T (MAIT) cells in the lungs are important for host defense against infections. This study demonstrates that MAIT cell activation during bacterial pneumonia caused by Klebsiella pneumoniae is independent of MR1 and driven by type I interferons (IFNs). Type I IFNs stimulate the activation and effector functions of MAIT cells and play a central role in their response to Klebsiella infection. This finding suggests that targeting type I IFNs could be a strategy to manipulate MAIT cell functions during bacterial infections.

JOURNAL OF EXPERIMENTAL MEDICINE (2023)

Article Oncology

Functional inhibition of the RNA-binding protein HuR sensitizes triple-negative breast cancer to chemotherapy

Lanjing Wei, Qi Zhang, Cuncong Zhong, Lily He, Yuxia Zhang, Ahlam M. M. Armaly, Jeffrey Aube, Danny R. R. Welch, Liang Xu, Xiaoqing Wu

Summary: Chemotherapy is the standard treatment for TNBC, but chemoresistance limits its efficacy. The RNA-binding protein HuR could be targeted to enhance chemotherapy efficacy. In this study, a docetaxel-resistant TNBC cell subline was established, and the HuR inhibitor KH-3 synergistically inhibited cell proliferation and tumor growth in combination with docetaxel, downregulated HuR targets, restored docetaxel's effects, induced apoptotic cell death and caused cell cycle arrest.

MOLECULAR ONCOLOGY (2023)

Article Oncology

PPM1D activity promotes the replication stress caused by cyclin E1 overexpression

Andra S. Martinikova, Miroslav Stoyanov, Anna Oravetzova, Yannick P. Kok, Shibo Yu, Jana Dobrovolna, Pavel Janscak, Marcel van Vugt, Libor Macurek

Summary: Oncogene-induced replication stress is a major cause of genome instability in cancer cells. This study reveals that increased activity of PPM1D exacerbates replication stress caused by cyclin E1 overexpression, leading to abnormal cell cycle progression and accumulation of DNA copy number alterations. Pharmacological inhibition of PPM1D can alleviate replication stress-induced genome instability.

MOLECULAR ONCOLOGY (2024)

Article Oncology

ALDH1A3 promotes invasion and metastasis in triple-negative breast cancer by regulating the plasminogen activation pathway

Alamelu G. Bharadwaj, Meghan E. McLean, Margaret L. Dahn, Hannah F. Cahill, Marie-Claire D. Wasson, Raj Pranap Arun, Olivia L. Walker, Brianne M. Cruickshank, Wasundara Fernando, Jaganathan Venkatesh, Penelope J. Barnes, Gillian Bethune, Gregory Knapp, Lucy K. Helyer, Carman A. Giacomantonio, David M. Waisman, Paola Marcato

Summary: ALDH1A3 regulates the plasminogen activation pathway to promote breast cancer metastasis. Co-expression of ALDH1A3 and tPA is associated with TNBC subtype, high tumor grade, and recurrent metastatic disease.

MOLECULAR ONCOLOGY (2024)

Article Oncology

Plasminogen deficiency suppresses pancreatic ductal adenocarcinoma disease progression

Nayela N. Chowdhury, Yi Yang, Ananya Dutta, Michelle Luo, Zimu Wei, Sara R. Abrahams, Alexey S. Revenko, Fenil Shah, Lindsey A. Miles, Robert J. Parmer, Bas de Laat, Alisa S. Wolberg, James P. Luyendyk, Melissa L. Fishel, Matthew J. Flick

Summary: Pancreatic ductal adenocarcinoma (PDAC) is a highly fatal metastatic disease associated with robust activation of the coagulation and fibrinolytic systems. Primary fibrinolytic protease plasminogen promotes PDAC tumor growth and metastatic potential through engaging plasminogen receptors on tumor cells.

MOLECULAR ONCOLOGY (2024)

Article Oncology

Ovarian cancer relies on the PDGFRβ-fibronectin axis for tumorsphere formation and metastatic spread

Nuria Gendrau-Sanclemente, Agnes Figueras, Kristina Gracova, Alvaro Lahiguera, Elisenda Alsina-Sanchis, Juan A. Marin-Jimenez, August Vidal, Xavier Matias-Guiu, Sergi Fernandez-Gonzalez, Marc Barahona, Lola Marti, Jordi Ponce, Francesc Vinals

Summary: High-grade serous ovarian cancer (HGSOC), the deadliest gynecological malignancy, spreads through transcoelomic dissemination. This study reveals that platelet-derived growth factor receptor beta (PDGFRβ) is essential for the formation of tumorspheres in HGSOC. Inhibition of PDGFRβ blocks the clustering of ovarian cancer cells and prevents peritoneal dissemination.

MOLECULAR ONCOLOGY (2024)